In a report released today, Charles Brennan from Jefferies maintained a Buy rating on Sage Group plc (SGE – Research Report), with a price target of p1,500.00. Charles Brennan’s rating is ...
Sage Therapeutics (SAGE) announced that its board of directors has initiated a process to explore strategic alternatives for the company. The board intends to evaluate a broad range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
